Russian Covid-19 Vaccine Trial India
- All
- News
- Videos
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
- Friday October 29, 2021
- India News | Press Trust of India
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
- www.ndtv.com
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
- Thursday May 13, 2021
- India News | Edited by Chandrashekar Srinivasan
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
- www.ndtv.com
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
- Friday January 22, 2021
- India News | ANI
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
- www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
- www.ndtv.com
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
- Tuesday December 1, 2020
- India News | NDTV
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
- www.ndtv.com
-
Bengal Likely To Lose Chance To Conduct Sputnik V Vaccine Phase II Trial
- Monday November 23, 2020
- India News | Press Trust of India
West Bengal will lose the chance to conduct Phase II clinical trial of Russian COVID-19 vaccine candidate Sputnik V because of the delay in grant of approval by the state government, a top official of an organisation involved in facilitating the exercise said on Sunday.
- www.ndtv.com
-
Russian Anti-COVID Vaccine Sputnik V To Be Tested On 100 Indian Volunteers
- Friday October 23, 2020
- India News | ANI
The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Russian news agency Sputnik on Thursday.
- www.ndtv.com
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
- Saturday October 17, 2020
- India News | Reuters
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
- www.ndtv.com
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
- Tuesday October 13, 2020
- India News | Press Trust of India
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
- www.ndtv.com
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
- Tuesday October 6, 2020
- India News | Press Trust of India
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
- www.ndtv.com
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
- Friday October 2, 2020
- India News | Press Trust of India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
- www.ndtv.com
-
India's New Coronavirus Infections At Lowest In Almost A Month
- Tuesday September 22, 2020
- India News | Reuters
India reported its lowest daily tally of coronavirus cases in almost a month on Tuesday as it prepares for clinical trials of a potential Russian vaccine in the next few weeks.
- www.ndtv.com
-
India Receives Offer For Russian Vaccine Trial, Manufacture: Official
- Tuesday September 8, 2020
- World News | Reuters
India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, a government official said on Tuesday.
- www.ndtv.com
-
Clinical Trial Of COVID-19 Vaccine, Sputnik V, To Begin In India This Month: Russia
- Tuesday September 8, 2020
- India News | ANI
The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
- www.ndtv.com
-
Dr Reddy's Hopes To Submit Sputnik V Light Trial Data To Drug Regulator In November
- Friday October 29, 2021
- India News | Press Trust of India
Dr Reddy's Laboratories Ltd is expected to submit Phase 3 trials data of single-dose Russian COVID-19 vaccine Sputnik Light to the Indian drug regulator next month, even as the city-based firm is getting ready to conduct trials of the jab in 2 to 18
- www.ndtv.com
-
"Trial Data Clear, Transparent...": Russian Scientists Defend Sputnik V
- Thursday May 13, 2021
- India News | Edited by Chandrashekar Srinivasan
Russian scientists leading clinical studies for the Sputnik V COVID-19 vaccine have responded to claims of "serious concerns over interim results from phase 3 trials" by stressing their data meets "clear and transparent standards..."
- www.ndtv.com
-
Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India
- Friday January 22, 2021
- India News | ANI
The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
- www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
- www.ndtv.com
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
- Tuesday December 1, 2020
- India News | NDTV
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
- www.ndtv.com
-
Bengal Likely To Lose Chance To Conduct Sputnik V Vaccine Phase II Trial
- Monday November 23, 2020
- India News | Press Trust of India
West Bengal will lose the chance to conduct Phase II clinical trial of Russian COVID-19 vaccine candidate Sputnik V because of the delay in grant of approval by the state government, a top official of an organisation involved in facilitating the exercise said on Sunday.
- www.ndtv.com
-
Russian Anti-COVID Vaccine Sputnik V To Be Tested On 100 Indian Volunteers
- Friday October 23, 2020
- India News | ANI
The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Russian news agency Sputnik on Thursday.
- www.ndtv.com
-
Russia Receives Renewed Approval For COVID-19 Vaccine Trials In India
- Saturday October 17, 2020
- India News | Reuters
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVID-19 vaccine, the sovereign wealth fund said on Saturday.
- www.ndtv.com
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
- Tuesday October 13, 2020
- India News | Press Trust of India
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
- www.ndtv.com
-
Dr Reddy's Asked To Reapply For Clinical Trials Of Russian COVID-19 Vaccine: Report
- Tuesday October 6, 2020
- India News | Press Trust of India
An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy's Laboratories to submit a revised protocol for conducting both phase-2 and 3 human clinical trials in India for the Russian vaccine, Sputnik V, against COVID-19, sources said.
- www.ndtv.com
-
Dr Reddy's Seeks Nod For Phase 3 Trial Of Russian Covid Vaccine In India
- Friday October 2, 2020
- India News | Press Trust of India
Hyderabad-based Dr Reddy's Laboratories has applied to the Drugs Controller General of India for permission to conduct phase-3 human clinical trials of the Russian vaccine Sputnik V against COVID-19 in India, sources said.
- www.ndtv.com
-
India's New Coronavirus Infections At Lowest In Almost A Month
- Tuesday September 22, 2020
- India News | Reuters
India reported its lowest daily tally of coronavirus cases in almost a month on Tuesday as it prepares for clinical trials of a potential Russian vaccine in the next few weeks.
- www.ndtv.com
-
India Receives Offer For Russian Vaccine Trial, Manufacture: Official
- Tuesday September 8, 2020
- World News | Reuters
India has received an offer from Russia to conduct a trial and manufacture its "Sputnik-V" COVID-19 vaccine, with several Indian companies currently studying the proposal, a government official said on Tuesday.
- www.ndtv.com
-
Clinical Trial Of COVID-19 Vaccine, Sputnik V, To Begin In India This Month: Russia
- Tuesday September 8, 2020
- India News | ANI
The clinical trials of Sputnik V vaccine for coronavirus will be held this month in several countries including India, confirmed Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF) on Monday.
- www.ndtv.com